The Africa CDC has announced plans to deploy a vaccine for the Zaire Ebola strain as a stop-gap measure against the current outbreak of the Bundibugyo strain in the Democratic Republic of Congo (DRC). This decision comes as the outbreak spreads rapidly, with cases confirmed in 51 health zones and a death rate six times faster than previous outbreaks.
Jean Kaseya, the director general of the Africa CDC, indicated that preliminary tests show the Zaire vaccine could significantly reduce mortality, even if it does not eliminate symptoms. The urgency of this deployment is underscored by ongoing strikes among medical staff, which could hinder response efforts in the affected regions.
In addition to the vaccine, authorities are considering the use of the antiviral drug remdesivir, which has shown promise in treating Ebola cases in neighboring Uganda. However, logistical challenges remain, particularly in remote areas where access to medical supplies is limited due to ongoing conflicts.
As health teams continue to monitor the situation, including screening travelers for symptoms, the focus remains on controlling the outbreak and preventing further spread. The situation highlights the critical need for effective response strategies in the face of rapidly evolving health crises.
Source: DW News
